Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
about
Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemiaA method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNAAntenatal hypoxia induces epigenetic repression of glucocorticoid receptor and promotes ischemic-sensitive phenotype in the developing heart.Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells.Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.Licochalcone A inhibits the migration and invasion of human lung cancer cells via inactivation of the Akt signaling pathway with downregulation of MMP-1/-3 expression.MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPEElevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer.VEGF as a potential target in lung cancer.MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1.miR‑15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl‑2 expression in human osteosarcoma cells.PTB-associated splicing factor inhibits IGF-1-induced VEGF upregulation in a mouse model of oxygen-induced retinopathy.Mithramycin A Alleviates Osteoarthritic Cartilage Destruction by Inhibiting HIF-2α Expression.MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1.lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma
P2860
Q28550699-EF048A1E-1058-4215-B0C6-4AC1F7C32245Q33732419-0EAE9177-3654-4AE8-931A-A4239991D7A9Q35156024-1628C1E0-A93C-4718-ADC9-13B4DC9EF75FQ36609727-B4B11BEE-1AF8-4AD6-918D-F7DC97891DD3Q37189474-10EEE7EF-E8FF-4D65-BC96-4DB47D0B80B8Q38696908-835F4BE6-D864-422A-91E2-D994F73FE276Q38899707-B16913D1-B34B-4E83-9A61-6F28DBEED773Q38963594-6587195B-1760-4699-80C0-D0F497F4F933Q38976579-453A643D-F703-42E8-B076-6F2CE8647F19Q41116778-E611C2C0-C6B1-4DF8-B032-ED86F0E02512Q41472140-761B837B-EF90-4062-B34D-9CA1798E4429Q47918409-0296B069-FA2D-4144-9DE2-54B060FD48D6Q48629938-0E89D064-5A29-4CA7-AD9F-E40832C1E22CQ52683999-809478E5-A4F6-45DB-97F1-C82668E67B66Q53630359-14A572E1-2288-46BC-9975-EBA9EB03519AQ54957861-9115F2A7-7F6B-4358-9285-2A0472D236E8Q55269717-33B70959-1BA5-44B1-838A-0305927532E1Q57482786-46E48361-74DC-4749-AC00-3CAE756FABB6
P2860
Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Elevated SP-1 transcription fa ...... in non-small cell lung cancer.
@ast
Elevated SP-1 transcription fa ...... in non-small cell lung cancer.
@en
type
label
Elevated SP-1 transcription fa ...... in non-small cell lung cancer.
@ast
Elevated SP-1 transcription fa ...... in non-small cell lung cancer.
@en
prefLabel
Elevated SP-1 transcription fa ...... in non-small cell lung cancer.
@ast
Elevated SP-1 transcription fa ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
Elevated SP-1 transcription fa ...... in non-small cell lung cancer
@en
P2093
David Onion
Karl Deacon
Rajendra Kumari
Susan A Watson
P2860
P304
39967-39981
P356
10.1074/JBC.M112.397042
P407
P50
P577
2012-09-18T00:00:00Z